Catalyst Wire Dossier Catalyst Wire Dossier

Froniglutide

PF1801 · Immunoforge Co. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Froniglutide, covering 2023-09-13 to 2023-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]

See pricing